9/7/2021MSD's KEYTRUDA Approved in China in Combo with Chemotherapy for First-...

9/7/2021GlobalData: China Leads Biosimilar Development and Marketing in APAC

9/7/2021Innovent and GenFleet Enter Global License Deal for GFH925 (KRAS G12C ...

9/7/2021Move over, Shanghai and Beijing? Suzhou wants to be the 'Pharmacy Vall...

9/6/2021NHSA Unveils the Draft Interim Regulations for Medical Insurance Inspe...

9/3/2021CDE Solicits Comments on the Technical Guidance on Clinical Trial of A...

9/3/2021CDE Solicits Comments on the Technical Guidance on Data Management and...

9/3/2021CDE Solicits Comments on the Technical Guidance on Application of Pati...

9/3/2021NHC Issues the Working Procedures for Adjustment of the List of Drugs ...

9/3/2021JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...

9/3/2021Innovent and GenFleet Ink Deal for KRAS Inhibitor

9/3/2021Arctic Vision Obtains China IND Clearance for PIII Study of ARVN003, F...

9/3/2021Inventiveness of Chinese Second Medical Use Patent: A Study From Top 1...

9/3/2021Wyeth Secured Win With Punitive Damages But Courts Had Different Opini...

9/3/2021Investment Prospects in China's Biopharmaceuticals and Biomaterials In...

9/3/2021Healthcare Sector Could Be the Next Target of Chinese Regulatory Crack...

9/1/2021What Are China's Pharma Prospects as the Country Enters Another New No...

9/1/2021NMPA Announces Package Insert Revision of Creatine Phosphate Sodium fo...

9/1/2021CDE Seeks Comments on Implementation Advice on ICH Guidelines E18, M3(...

9/1/2021CDE Solicits Comments on the Technical Guidance on Clinical Protocol f...

9/1/2021Junshi Bio and Coherus Completes Rolling BLA Submission of Toripalimab...

9/1/2021CStone Files Chinese NDA of Sugemalimab for Stage III NSCLC

9/1/2021U.S. FDA Apprves BeiGene's BRUKINSA (Zanubrutinib) for Waldenström's ...

9/1/2021Harbour BioMed Gets Chinese IND Approval for PII Trial of Anti-FcRn Ba...

8/31/2021Insilico and 4B Tech Tie Up to Advance Drug Discovery for Neurodegener...

8/31/2021NHSA Issues the Notice on the Public Service Item List of Centralized ...

8/31/2021Financial-related Company News in Brief (August 2021)

8/31/2021Eight Central Government Agencies Issues the Pilot Plan for Deepening ...

8/31/2021Jingxin In-licenses Epilepsy Drug from Bio-Pharm Solutions for $40M

8/31/2021HUYABIO Files an IND with the FDA for the Novel SHP2 Inhibitor HBI-237...

Page:186/789 Total number of articles:23668: [First][<<] [184] [185] [186] [187] [188] [>>] [End]